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Abstract Cytochrome P450 monooxygenases are valuable
biocatalysts due to their ability to hydroxylate unactivated
carbon atoms using molecular oxygen. We have cloned the
gene for a new cytochrome P450 monooxygenase, named
CYP154H1, from the moderately thermophilic soil bacte-
rium Thermobifida fusca. The enzyme was overexpressed
in Escherichia coli at up to 14% of total soluble protein and
purified to homogeneity in three steps. CYP154H1 activity
was reconstituted using putidaredoxin reductase and puti-
daredoxin from Pseudomonas putida DSM 50198 as
surrogate electron transfer partners. In biocatalytic reactions
with different aliphatic and aromatic substrates of varying
size, the enzyme converted small aromatic and arylaliphatic
compounds like ethylbenzene, styrene, and indole. Further-
more, CYP154H1 also accepted different arylaliphatic
sulfides as substrates chemoselectively forming the
corresponding sulfoxides and sulfones. The enzyme is
moderately thermostable with an apparent melting temper-
ature of 67°C and exhibited still 90% of initial activity after
incubation at 50°C.
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Introduction
Cytochrome P450 monooxygenases (E.C. 1.14) form a
large and diverse class of enzymes with currently >9,000
members (Nelson 2009). They are widely distributed in
nature where they play important roles in the assimilation
of carbon sources, the detoxification of xenobiotics, or the
synthesis of secondary metabolites (Ortiz de Montanello
2005). Due to their ability to catalyze highly diverse
chemical reactions using molecular oxygen, e.g., hydroxyl-
ation of non-activated carbon atoms, epoxidation of double
bonds, oxidation of heteroatoms, dealkylations, etc. (Isin
and Guengerich 2007), P450s are highly interesting and
valuable biocatalysts (Bernhardt 2006). Cytochrome P450
monooxygenases contain a heme prosthetic group and
depend on electron transfer components which deliver
electrons from the cofactor to the heme iron during
catalysis. Depending on the kind of electron transfer
partners and their organization, P450s are divided into
different classes (Hannemann et al. 2007). Class 1
comprises bacterial (soluble) and mitochondrial (mem-
brane-bound) three-component P450 monooxygenases that
besides the P450 monooxygenase consist of a ferredoxin
reductase and a ferredoxin which shuttle electrons from the
cofactor NAD(P)H to the monooxygenase component.
The best studied bacterial three-component P450 mono-
oxygenase is CYP101A1 (P450cam) from Pseudomonas
putida DSM 50198. Together with its electron transfer
partners putidaredoxin reductase (PdR) and putidaredoxin
(Pdx), it catalyzes the first step in the degradation of
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camphor by stereospecific hydroxylation of the substrate
giving 5-exo-hydroxycamphor (Hedegaard and Gunsalus
1965). One special feature of the P450cam system is that all
three components necessary for camphor hydroxylation in P.
putida are encoded together in one operon. In contrast, for
many other bacterial three-component P450 monooxyge-
nases, the natural electron transfer partners are not known.
Since it was found that putidaredoxin is also able to deliver
electrons to a range of other bacterial P450s, PdR and Pdx
have been used as substitute electron transfer partners
(Agematu et al. 2006; Furuya and Kino 2009). However,
the electron transfer efficiency varies significantly which
may lead to rather high uncoupling of NADH consumption
and substrate oxidation.
So far, only few thermostable P450 monooxygenases are
described in the literature, most of them of archaeal origin.
The best studied archaeal P450 is CYP119, a hyperthermo-
stable enzyme from Sulfolobus solfataricus. It was shown to
epoxidize styrene and cis-stilbene and to hydroxylate fatty
acids (Koo et al. 2000, 2002; McLean et al. 1998). The
crystal structure was solved and the natural electron donors
of this system were discovered to consist of a ferredoxin and
a 2-oxoacid-ferredoxin reductase (Puchkaev and Ortiz de
Montellano 2005; Yano et al. 2000). The only characterized
thermostable P450 monooxygenase of bacterial origin is
CYP175A1 from Thermus thermophilus, an enzyme dis-
playing β-carotene hydroxylase activity (Blasco et al. 2004).
Its crystal structure was also solved and recently the natural
electron donor partners, a ferredoxin and a NADPH-
dependent ferredoxin reductase, were identified (Mandai et
al. 2009; Yano et al. 2003).
The moderately thermophilic soil bacterium Thermobi-
fida fusca with an optimum growth temperature of 50–55°C
belongs to the phylum of Actinobacteria and is a major
degrader of plant cell walls in heated organic materials
(Bachmann and McCarthy 1991). This bacterium is of high
interest due to the secretion of different thermostable
cellulolytic enzymes that display high activity and a broad
pH range (Wilson 2004). Recently, the genome sequence of
this actinomycete was published (Lykidis et al. 2007). The
single chromosome contains ten different genes encoding
putative cytochrome P450 monooxygenases of which four
belong to family CYP154. To the same family belong
currently 18 members, all P450s originating from actino-
mycetes (Nelson 2009). However, only few of them have
been studied so far. CYP154C1 from Streptomyces coeli-
color A3(2) was shown to convert the macrolides narbo-
mycin and YC-17 to pikromycin and neomethymycin,
respectively (Podust et al. 2003), whereas CYP154 from
Nocardia farcinica IFM 10152 hydroxylates testosterone
(Agematu et al. 2006). Also the crystal structures of two
members of this family, CYP154A1 and CYP154C1 from
S. coelicolor A3(2), were determined revealing an unusual
180° flip of the heme in the active site of CYP154A1
(Podust et al. 2003, 2004). Besides that, none of the P450
monooxygenases belonging to family CYP154 has been
characterized in detail yet.
We became interested in CYP154H1 from T. fusca during
our work on steroid hydroxylation, since the enzyme
exhibits 46% sequence identity at the protein level with
CYP154 from N. farcinica IFM 10152, an enzyme that regio-
and stereoselectively hydroxylates testosterone (Agematu et
al. 2006). Furthermore, CYP154H1 shares 52% sequence
identity at the protein level with CYP154C1 from S.
coelicolor A3(2), of which the three-dimensional structure
was solved, allowing us to generate a structural model of
CYP154H1. Additionally, the anticipated higher thermal
stability makes the enzyme an attractive candidate for
biocatalytic applications. In this study, we report on the
recombinant expression, purification, and characterization of
CYP154H1, a new moderately thermostable bacterial P450
monooxygenase from T. fusca.
Materials and methods
Materials
All chemicals were purchased from Sigma-Aldrich (Zwijn-
drecht, The Netherlands), unless otherwise specified.
Isopropyl-1-thio-β-D-galactopyranoside (IPTG) was obtained
from Roth GmbH (Karlsruhe, Germany).
DNA primers were obtained from Sigma Genosys
(Germany). DNA-modifying enzymes were purchased from
New England Biolabs (Beverly, MA, USA).
Bacterial strains and plasmids
The Escherichia coli TOP10 strain (Invitrogen, Carlsbad,
CA, USA) was used for genetic manipulations, while E.
coli C43(DE3) was used for expressions. Strain P. putida
DSM 50198 was obtained from the DSMZ (Braunschweig,
Germany), and strain T. fusca was kindly provided by Dr.
Diana Irwin (Cornell University, New York, NY, USA).
Plasmids pACYC-Duet1 and pET28a(+) were pur-
chased from Novagen (EMD Biosciences, San Diego,
CA, USA). The broad host-range expression vector
pIT2-MCS was derived from vector pBBR1 (Kovach
et al. 1994; kindly provided by Kenneth Peterson,
Louisiana State University Medical Center, Shreveport,
LA, USA) by introduction of the trc promotor from
pKK233-2 (Takara Bio Europe/Clontech, Saint-Germain-
en-Laye, France), exchanging the bla ampicillin resistance
gene by the tet gene conferring tetracycline resistance and
introduction of the multiple cloning site of vector pBAD/
Myc-His (Invitrogen).
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Cloning of cyp154H1, camA, and camB
The gene of CYP154H1 was amplified by PCR from
genomic DNA of T. fusca using primers TF-P-NdeI-FW:
5 ′ -GGAGGTCACATATGGCTTCGCCTACCGA-
C AAT CCG - 3 ′ a n d T F - P -H i n d I I I - RV: 5 ′ -
GTTTTGCGGGAAGCTTACGGGCGCAGGATGAC-3′.
Thereby restriction sites NdeI and HindIII were introduced
for subsequent cloning of cyp154H1 into vector pIT2-
MCS. The resulting vector was named pIT2cyp154H1.
Genes camA and camB coding for PdR and Pdx,
respectively, were amplified by PCR from genomic DNA
of P. putida DSM 50198 using primers PP-R-BspHI-FW:
5′-AAAAAAAATCATGAACGCAAACGACAACGTGG-
3′ and PP-R-SacI-RV: 5′-ATTTAGAGCTCAGGCAC-
TACTCAGTTCAGCTTTGG-3′ for camA as well as PP-
X-NdeI-FW: 5′-AGGATAATCATATGTCTAAAGTAGTG-
TAT G T G T C - 3 ′ a n d P P - X - X h o I - RV : 5 ′ -
TTTTTTTTCTCGAGGTTTACCATTGCCTATCG-3′ for
camB. The PCR product carrying the camA gene was
digested with BspHI and SacI and ligated into vector
pACYC-Duet1 cut with NcoI and SacI. The resulting
vector, named pACYCcamA, was then used as template
in a QuikChange site-directed mutagenesis PCR to remove
the XhoI site present in camA. The PCR was performed
according to the manufacturer’s instructions using primers
QC-R-XhoI-FW: 5 ′-ATACCTGCGCACACTGGAG-
GACGCCGAGTGCATTC-3′ and QC-R-XhoI-RV: 5′-
AATGCACTCGGCGTCCTCCAGTGTGCGCAGGTATC-
3′. The resulting vector was digested with NdeI and XhoI
and ligated with the camB gene, previously cut with the
same pair of enzymes. The final plasmid was named
pACYCcamAB. Similarly, camB digested with NdeI and
XhoI was also ligated into pACYC-Duet1 to give vector
pACYCcamB.
Expression of CYP154H1 together with Pdx and PdR
in E. coli
E. coli C43(DE3)(pACYCcamAB)(pIT2cyp154H1) cells
were grown in 500 ml TB medium containing 25 μg ml−1
chloramphenicol and 10 μg ml−1 tetracycline (TBCm, Tc) at
37°C to an optical density at 600 nm of 1. Then, 0.8 mM
IPTG and 0.5 mM δ-amino levulinic acid (δ-ala) were added
to start protein expression, and the culture was incubated for
another 48 h at 28°C. The cells were harvested by
centrifugation at 5,000×g for 20 min and washed once with
50 mM potassium phosphate buffer, pH 7.5. The cell pellet
was resuspended in 20 ml of the same buffer and sonicated
for 15 min (15 s on, 30 s off, 70% amplitude) on ice. Cell
debris was removed by centrifugation at 31,000×g for 45 min
at 4°C. The resulting cell-free extract was stored at −20°C
after addition of 10% glycerol.
Purification of CYP154H1
For easy purification of CYP154H1 via an N-terminal his6-
tag, the corresponding gene was subcloned from plasmid
pIT2cyp154H1 into pET28a(+) using restriction enzymes
NdeI and HindIII. The resulting plasmid was named
pET28cyp154H1 and transformed into E. coli C43(DE3)
for expression. E. coli C43(DE3) cells containing pET28-
cyp154H1 were grown in 500 ml TB medium supple-
mented with 50 μg ml−1 kanamycin at 37°C to OD600=1.0.
At this point, 0.8 mM IPTG and 0.5 mM δ-ala were added
to start protein expression, and the culture was incubated
for another 48 h at 30°C. The cells were harvested by
centrifugation at 5,000×g for 20 min and washed once with
50 mM potassium phosphate buffer, pH 7.5. The cell pellet
was resuspended in 20 ml of the same buffer and sonicated
for 15 min (15 s on, 30 s off, 70% amplitude) on ice. Cell
debris was removed by centrifugation at 31,000×g for
45 min at 4°C. The resulting cell-free extract was heated for
30 min at 50°C and centrifuged afterwards for 15 min at
17,000×g and 4°C to remove denatured protein. The
supernatant carrying active CYP154H1 was afterwards
loaded on a 60-ml Q Sepharose FF column (GE Healthcare,
Hoevelaken, The Netherlands) equilibrated with 50 mM
potassium phosphate buffer, pH 7.5. The column was
washed with three column volumes of the same buffer
before elution of CYP154H1 with a linear gradient of 0–
500 mM KCl in 50 mM potassium phosphate buffer,
pH 7.5. Fractions with the highest A416/A280 ratio were
combined and concentrated by ultrafiltration using a 30-
kDa cutoff membrane. This protein concentrate was then
loaded on a 5-ml HisTrap HP column (GE Healthcare)
equilibrated with 50 mM potassium phosphate buffer,
pH 7.5. The column was washed with the same buffer
containing 20 mM imidazole until all unbound protein was
removed. Finally, CYP154H1 was eluted using 50 mM
potassium phosphate buffer containing 200 mM imidazole,
pH 7.5, and desalted using Econo-Pac 10DG columns (Bio-
Rad Laboratories B.V., Veenendaal, The Netherlands) and
50 mM potassium phosphate buffer, pH 7.5. Purified
CYP154H1 was concentrated by ultrafiltration using a 30-
kDa cutoff membrane and stored at −20°C after addition of
10% glycerol.
Purification of PdR and Pdx
PdR expression was performed at 30°C for 48 h using E. coli
C43(DE3)(pACYCcamA). The protein was purified from
CFE according to the protocol of Sevrioukova et al. (2001).
Expression of Pdx was also performed at 30°C for 48 h
using E. coli C43(DE3)(pACYCcamB). Purification of Pdx
from CFE was carried out according to a published protocol
(Sevrioukova et al. 2003).
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Enzyme assays
CYP154H1 concentration was determined by measuring
CO-difference spectra (Omura and Sato 1964). The amount
of P450 was calculated based on the maximum absorbance
of CO-bound P450 at 450 nm (ε450=91 mM
−1 cm−1).
Putidaredoxin reductase activity was determined by moni-
toring the decrease in ferricyanide concentration at 420 nm
(ε420=1.02 mM
−1 cm−1; Roome et al. 1983).
Putidaredoxin activity was determined by monitoring the
reduction of cytochrome c at 550 nm (ε550=19.1 mM
−1 cm−1)
with PdR as electron-supplying reductase (Lacour et al.
1998). Similarly, activity of PdR and Pdx together in CFE of
E. coli C43(DE3) (pACYCcamAB)(pIT2cyp154H1) was
also measured using the cytochrome c reduction assay.
Bioconversions
All enzyme reactions for determining the substrate scope of
CYP154H1 were first carried out using CFE of E. coli C43
(DE3)(pACYCcamAB)(pIT2cyp154H1) and later con-
firmed in reactions using purified CYP154H1, Pdx, and
PdR. Bioconversions using CFE were performed in 10 ml
closed glass tubes at 30°C with shaking. Small-scale
reactions of 1 ml total volume consisted of 0.5 ml CFE
(containing CYP154H1, Pdx, and PdR), 50 μM NADH,
and 5 mM substrate (as 1 M stock in ethanol) as well as
150 mM sodium formate and 0.5 U formate dehydrogenase
(FDH; Sigma-Aldrich) for cofactor regeneration in 50 mM
potassium phosphate buffer. Reactions were extracted with
each 500 μl ethyl acetate containing 0.5% dodecane as
internal standard. Organic phases were dried over anhy-
drous sodium sulfate and analyzed by GC, GC-MS, and
HPLC. Conversions were usually calculated from relative
peak areas of products after GC analysis using a standard
curve. In case of complex product mixtures, conversions
were calculated from respective relative peak areas of
substrates.
Bioconversions using purified CYP154H1, Pdx, and
PdR were performed accordingly containing 10 μM
CYP154H1, 10 μM PdR, and 30 μM Pdx instead of
CFE. Furthermore, sodium formate concentration was
lowered to 50 mM since no other NADH-consuming
enzymes besides PdR were present and 300 U/ml catalase
was added to efficiently remove H2O2. Catalase addition
was not necessary in the case of conversions using CFE due
to E. coli-born catalase activity.
Kinetic measurements and coupling efficiency
NADH oxidation rates were measured spectrophotometri-
cally at 30°C using purified P450, PdR, and Pdx by
following NADH absorbance at 340 nm over time. The
reaction mixture typically contained 1 μM PdR, 5 μM Pdx,
1 μM CYP154H1, and 5 mM substrate (1 M stock in
DMSO) in 50 mM potassium phosphate buffer, pH 7.5.
Reactions were started by adding 100 μM NADH (ε340=
6.22×103 M−1 cm−1). All measurements were done in
triplicate.
After complete oxidation of cofactor NADH, each 200-
μl reaction mix was used to measure the amount of H2O2
that was formed during the reaction. This was done
according to a protocol by Heuts et al. (2007).
Turnover numbers for the conversion of ethylbenzene
(1) and styrene (8) by CYP154H1 were determined by
following product formation in time using GC. Reactions of
5 ml total volume consisted of 2 μM P450, 4 μM PdR,
20 μM Pdx, 5 mM substrate (1 M stock in ethanol),
150 mM sodium formate, 0.5 U FDH, 10 U catalase, and
100 μM NADH in 50 mM potassium phosphate buffer,
pH 7.5. Reactions were incubated at 30°C with shaking,
and samples of each 1 ml volume were taken over a period
of 60 min. Samples were extracted and analyzed by GC as
described under “Bioconversions”.
Determination of thermostability
The apparent melting temperature of CYP154H1 was
determined by measuring ellipticity at 220 nm for increas-
ing temperatures on a Jasco J-815 CD spectrometer (Jasco
Inc, Easton, MD, USA). A 1-ml sample of 35 μg/ml
purified P450 in 50 mM potassium phosphate buffer,
pH 7.5, was heated from 35°C to 100°C with a rate of
0.5°C/min. Every 30 s, the ellipticity was measured at
220 nm. The obtained data were plotted against the
temperature and the transition point of the resulting graph
corresponds to the apparent melting temperature.
Additionally, thermal stability of purified CYP154H1
was determined by measuring the residual activity of the
enzyme at 25°C after incubation at higher temperatures.
Thus, a 1-μM solution of CYP154H1 in 50 mM potassium
phosphate buffer, pH 7.5, was heated with 2°C/min to
various temperatures between 40°C and 100°C and incu-
bated for 10 min at the respective temperature before
cooling down again to 25°C with 2°C/min. The residual
activity of the enzyme was determined by measuring the
decrease in NADH absorbance at 340 nm. The reaction
mixture contained 0.1 μM PdR, 1 μM Pdx, 0.1 μM
CYP154H1, and 2 mM ethylbenzene in 50 mM potassium
phosphate buffer, pH 7.5. Reactions were started by adding
100 μM NADH.
GC, GC-MS, and HPLC analyses
Achiral GC analysis was performed on a Shimadzu GC14
gas chromatograph equipped with an AT-5 column (Grace,
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Deerfield, IL, USA). The temperature profile for the
column was as follows: linear gradient starting at 40°C
and heating with 10°C/min to 300°C. Injector and detector
temperature were set to 300°C. Retention times were as
follows: 1, 4.8 min; 2, 7.9 min; 3, 8.0 min; 4, 6.2 min; 5,
9.3 min; 6, 9.0 min; 7, 9.5 min; 8, 5.2 min; 9, 8.0 min; 10,
8.7 min; 11, 11.4 min; 16, 14.2 min; 17, 17.0 min; 18,
14.7 min; 20a, 8.3 min; 20b, 9.2 min; 20c, 9.9 min; 20d,
9.6 min; 21a, 11.9 min; 21b, 13.1 min; 21c, 13.5 min; 21d,
13.9 min; 22a, 12.8 min; 22b, 13.9 min; 22c, 14.3 min;
22d, 14.4 min; 23, 18.3 min; and 24, 20.3 min. GC-MS
measurements were performed on an Agilent HP 6890 gas
chromatograph with a HP5973 MS detector equipped with
a HP1 column (Agilent, Santa Clara, CA, USA) using the
same temperature profile.
Chiral GC analysis of sulfoxides 21a–d was performed
on an Agilent HP 6890 gas chromatograph equipped with a
Chiraldex G-TA column (Astech, Whippany, NJ, USA).
The column was heated at 160°C; injector and detector
temperature were set to 200°C. Retention times were as
follows: (R)-21a, 5.8 min; (S)-21a, 7.3 min; (R)-21b,
6.9 min; (S)-21b, 8.3 min; (R)-21c, 7.7 min; (S)-21c,
8.1 min; (R)-21d, 13.5 min; and (S)-21d, 9.4 min.
Chiral HPLC measurements were performed with a
Shimadzu LC instrument consisting of a CTO-10A column
oven, a SIL-10AD autoinjector and a SPD-M10A diode
array detector using different chiral columns (Chiral
Technologies Europe, Illkirch-Cedex, France) and varying
heptane/isopropanol mixtures as running solvent (Table 1).
The flow rate was set to 1 ml/min. Absolute configurations
were determined by comparison to enantiomerically pure
standards.
Results
Cytochrome P450 monooxygenases from T. fusca
In the genome sequence of the moderately thermophilic soil
bacterium T. fusca, a total of ten open reading frames
coding for putative cytochrome P450 monooxygenases
were identified (Nelson 2009). A high number of P450-
encoding genes are also present in the genome sequences of
other actinomycetes such as Streptomyces sp. or Nocardia
sp. which produce P450s that are mainly involved in
secondary metabolism (Lamb et al. 2003).
According to the P450 classification, four of the P450s
from T. fusca belong to family CYP154 (namely CYP154E1,
CYP154F1, CYP154G1, and CYP154H1) and one to family
CYP157 (CYP157A3), whereas the other five (namely
CYP215A1, CYP216A1, CYP217A1, CYP218A1, and
CYP222A1) constitute new families (Nelson 2009). A
BLAST search revealed that there are no homologs of
CYP216A1, CYP218A1, and CYP222A1 with >40%
sequence identity at the protein level present in the non-
redundant protein (nr) and Swissprot databases and that
would fall into the same CYP families. Thus, P450
monooxygenases CYP216A1, CYP218A1, and CYP222A1
are the only members of their respective family so far, and
no close homologs of identified functionality are known. For
CYP157A3 and CYP215A1, other members of the same
families can be found in the nr and Swissprot databases, but
none of these proteins has been studied until now. The
CYP217A1 gene likely is part of a polyketide synthesis
(PKS) gene cluster. The closest homologs of CYP217A1 that
are present in Streptomyces albaduncus and Streptomyces
griseoflavus are part of PKS clusters involved in the
synthesis of chrysomycin and gilvocarcin V, respectively
(Fischer et al. 2003; Kharel et al. 2010).
According to the phylogenetic tree in Fig. 1, none of the
P450s from T. fusca is closely related to known thermosta-
ble P450s originating from various archaea or the bacterium
T. thermophilus. Cytochrome P450s CYP154E1,
CYP154F1, CYP154G1, and CYP154H1 belong to one
family of P450 monooxygenases and thus also fall into one
clade. However, CYP154H1 is more distantly related to the
other three P450s as it lies in another branch of the same
subtree. The closest homologs of CYP154H1 with known
functionality are CYP154C1 from S. coelicolor and
CYP154 from N. farcinica sharing 52% and 46% sequence
identity at the protein level with CYP154H1. Since these
enzymes were shown before to catalyze the conversion of
several macrolides and the hydroxylation of testosterone,
respectively (Agematu et al. 2006; Podust et al. 2003), we
decided to characterize CYP154H1 in more detail.
Cloning and recombinant expression of CYP154H1
The gene of CYP154H1 was amplified from genomic DNA
using PCR and cloned into the broad host-range vector pIT2-
MCS, which contains an IPTG-inducible trc promoter and a
tetracycline resistance gene. Putidaredoxin and putidaredoxin
reductase from P. putida DSM50198 served as electron
transfer components in bioconversions (Peterson et al. 1990).
The corresponding genes were also amplified by PCR from
Table 1 HPLC analysis of chiral products 2, 5, 6, and 9
Compound Column Heptane/
isopropanol
Retention time
(min)
2 OD 95:5 7.9 (R), 8.7 (S)
5 OD 99:1 18.7 (R), 20.3 (S)
6 OD 99:1 14.5, 16.1
9 AS 99:1 6.3 (R), 7.4 (S)
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genomic DNA of this strain and cloned into the vector
pACYCDuet-1 that contains two T7 promoters and a
chloramphenicol resistance gene. Thereby, each gene was
put behind a separate promoter. For efficient coexpression of
all three proteins in one host, E. coli C43(DE3) was used,
which is an E. coli BL21(DE3) mutant specially suited for
recombinant expression of difficult proteins (Miroux and
Walker 1996). Thus, much higher levels of soluble PdR and
less inclusion bodies could be obtained for expression in E.
coli C43(DE3) at 30°C compared to E. coli BL21(DE3).
Protein expression was induced by IPTG addition and δ-
aminolevulinic acid was added for enhanced heme synthesis.
Using this expression system, CYP154H1 was produced at
up to 4% of the total soluble protein, and a specific activity
of the electron transfer components of ≥1 U/mg total protein
was obtained under optimized conditions as determined by
the cytochrome c reduction assay.
Purification of CYP154H1
For easy purification of CYP154H1, the corresponding
gene was subcloned into vector pET28a(+) to generate an
N-terminal his6-tagged protein. Recombinant expression
was also performed in E. coli C43(DE3) at 28°C yielding
up to 14% P450 of total soluble protein with a molecular
weight of 48 kDa. The enzyme was purified to homogene-
ity in three steps (Table S1, Figure S1, Online Resource): a
heating step (30 min at 50°C), anion exchange chromatog-
raphy using a Q Sepharose column, and immobilized metal
affinity chromatography taking advantage of the N-terminal
his6-tag. Thus, 140 mg of pure CYP154H1 could be
obtained from a 500-ml culture as determined by CO-
difference spectra.
Substrate spectrum of CYP154H1
To explore the range of substrates that can be converted by
CYP154H1, different aliphatic and aromatic compounds of
varying size were tested in bioconversions with CFE contain-
ing PdR, Pdx, and P450. It was found that the enzyme was
active with small arylaliphatic substrates like ethylbenzene (1)
and styrene (8; Scheme 1; Table 2) which were exclusively
hydroxylated or epoxidized at the aliphatic side chain. In
contrast, toluene, anisole, and dimethoxybenzene were
Fig. 1 Phylogenetic tree of the
cytochrome P450 monooxyge-
nases from T. fusca and their
closest homologs together with
known hyperthermostable P450s.
The multiple sequence alignment
was made using ClustalX version
2.0.12. The phylogenetic tree
was constructed by the neighbor-
joining method and was sche-
matically presented using the
ClustalX output and MEGA ver-
sion 4 (Tamura et al. 2007).
Prefixes in front of the CYP
number abbreviate the genus and
species of the respective bacterial
organism where the enzyme
originates from (Tf T. fusca, Nd
Nocardiopsis dassonvillei, Nf
Nocardia farcinica, Sal Strepto-
myces albaduncus, Sco Strepto-
myces coelicolor, Sgr
Streptomyces griseoflavus, Shy
Streptomyces hygroscopicus, Ssp
Streptomyces sp., Sso Sulfolobus
solfataricus, Sto Sulfolobus toko-
daii, Pt Picrophilus torridus, Tt
Thermus thermophilus). P450s
from T. fusca are shown in red;
hyperthermostable P450s are
given in blue. The bar in the
lower left corner represents 0.1
amino acid substitutions per
amino acid for the branch length
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hydroxylated at the aromatic ring, but conversions were only
below 5%. Phenol and naphthalene were not substrates of
CYP154H1. Of the tested aliphatic compounds, cyclohex-
ane, cyclohexene, cyclohexanone, testosterone, and lauric
acid methyl ester were not converted whereas 1-octene was
transformed into the corresponding epoxide and 3-hydroxy-
1-octene in a 2:1 ratio.
In the case of the arylaliphatic hydrocarbons ethylben-
zene (1), propylbenzene (4), and styrene (8), chiral products
(R)-1-phenylethanol ((R)-2), (R)-1-phenyl-1-propanol ((R)-
5) and (S)-styrene oxide ((S)-9), respectively, were formed
by CYP154H1 with low to moderate enantiomeric excess.
The enantioselectivity seems to increase with increasing
length of the aliphatic side chain giving 5 with 66% ee.
Interestingly, CYP101A1 (P450cam) gives also preferably
(S)-styrene oxide as product in the conversion of 8, while
CYP102A1 (P450BM3) and CYP108A1 (P450terp) prefer-
entially produce the (R)-epoxide (Fruetel et al. 1994). In all
three cases, the enantiomeric excess of the formed products
are also only low to moderate. In the conversion of
propylbenzene (4) by CYP154H1, small amounts of 1-
phenyl-2-propanol (6) were also detected, but the enantio-
meric excess was below 2%. To rule out that some of the
identified products are not formed by CYP154H1 but by
other enzymes present in the CFE, all bioconversions were
also tested using CFE of E. coli C43(DE3)(pACYCca-
mAB) not expressing CYP154H1 (negative control). For
none of the substrates, product formation was detected in
these negative controls. Furthermore, all bioconversions
were also carried out using purified PdR, Pdx, and P450 in
order to investigate if some of the initially formed products
were further converted by E. coli enzymes (e.g., oxidation
of formed alcohols to the respective ketones). However, in
all cases, products were the same as in reactions with CFE
indicating that the formation of these products was due to
P450 activity.
CYP154H1 also converted indole (11), forming a
mixture of indigo (14) and indirubin (15) already during
coexpression of PdR, Pdx, and the P450 in E. coli. This
became evident by a blue to violet coloration of the cell
pellet and the presence of a blue and a pink band on TLC
after extraction. Thus, indole (11), N-acetylindole (16), and
3-acetylindole (19) were also tested in bioconversions using
CFE. It appeared that only 11 and 16 were transformed with
44% and 70% conversion, respectively, whereas 19 was not
converted. This could be explained by a preferential
hydroxylation of the indole ring at the 3-position leading
to autocatalytic dimerization with formation of products 14
and 15 in the case of indole (Scheme 2). Accordingly, for
substrate 16, the main product was found by GC-MS to be
3-oxo-N-acetylindole (17) and in much smaller amounts
also the corresponding 2-oxo product 18 was formed (ratio
4:1, respectively).
To investigate, if CYP154H1 is also able to chemo-
selectively oxidize organic sulfides, reactions with CFE
containing PdR, Pdx as well as P450 and different arylali-
phatic sulfides (20a–d) were carried out. The enzyme
converted 20a–d to the corresponding sulfoxides 21a–d
and further to the sulfones 22a–d (Scheme 3, Table 3), with
the sulfoxides as the main products. Product ratios of 21:22
varied significantly depending on the used substrate. The ee
values of the different chiral sulfoxides were low to
moderate. Interestingly, the stereopreference of the enzyme
changed from R to S with increasing size of the aromatic
Table 2 Conversion of 1, 4, and 8 by CFE of E. coli C43(DE3)
(pACYCcamAB)(pIT2cyp154H1) containing active CYP154H1
from T. fusca as well as PdR and Pdx from P. putida (5 mM
substrate, 30°C)
Substrate Conversion (%) Product ratio ee (%)
1 47 88(2):12(3) 43 ((R)-2)
4 35 79(5):7(6):14(7) 66 ((R)-5)
8 53 81(9):19(10) 13 ((S)-9)
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Scheme 1 Conversion of ethyl-
benzene (1), propylbenzene
(4), and styrene (8) by
CYP154H1 from T. fusca.
CamA (PdR) and CamB
(Pdx) served as electron
transfer components
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substituent. While 20a was converted to the (R)-sulfoxide
with 56% ee, addition of a methyl group in para-position at
the phenyl ring (20c) or replacement of the phenyl by a
benzyl moiety (20d) led to the formation of (S)-sulfoxide
with 20% and 46% ee, respectively. Such a change in
stereopreference in the oxidation of thioanisole (20a) and p-
methyl thioanisole (20c) was also found for CYP101A1
(P450cam) yielding (R)-21a and (S)-21c with 44% and 4% ee,
respectively (Fruetel et al. 1994). In the conversion of 20b
by CYP154H1, two more products were detected, which
were identified by GC-MS to be diphenyldisulfide (23) and a
corresponding sulfone (24; Figure S2, Online Resource). The
latter are probably formed through S-dealkylation of the
substrate instead of S-oxidation (Watanabe et al. 1981). Both
products were also found in incubations with purified
CYP154H1 but not in control reactions with CFE of E. coli
C43(DE3)(pACYCcamAB), confirming that their formation
depends on the presence of P450.
Kinetics and coupling efficiency
Usually a significant rate of uncoupling between electron
transfer to the heme and substrate hydroxylation is
observed for conversions of non-natural substrates or when
artificial electron transfer partners are applied in biocon-
versions with P450 monooxygenases. Thus, turnover
numbers (TN) for different substrates should be determined
based on product formation rates rather than measuring the
rates of cofactor (NADH) oxidation. For CYP154H1, TN
for ethylbenzene (1) and styrene (8) conversion at 30°C
were determined using purified PdR, Pdx, and P450 by
following product formation in time. Using 5 mM substrate,
TN for 1 and 8 were calculated to be 0.28 and 0.31 nmol-
min−1 nmol−1 P450, respectively. In contrast, corresponding
NADH oxidation rates for 1 and 8 with 5.2 and 4.6 nmol-
min−1 nmol−1 P450, respectively, were ≥15-fold higher,
indicating rather low coupling efficiencies. This was also
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Scheme 2 Conversion of indole derivatives 11, 16, and 19 by CYP154H1 from T. fusca. CamA (PdR) and CamB (Pdx) served as electron
transfer components
S R
1 R1 R1
R2 R2 R2
n Sn Sn
NADH
O2
NAD+
H2O
+
O O
O
20a-d 21a-d 22a-d
a: R1 = Me, R2 = H, n = 0
b: R1 = Et, R2 = H, n = 0
c: R1 = Me, R2 = Me, n = 0
d: R1 = Me, R2 = H, n = 1
CYP154H1
CamAB
Scheme 3 Oxidation of sulfides
20a–d by CYP154H1 from
T. fusca. CamA (PdR) and
CamB (Pdx) served as
electron transfer
components
1482 Appl Microbiol Biotechnol (2011) 89:1475–1485
confirmed by the detection of high amounts of H2O2 that
were produced during measurements of NADH oxidation
(data not shown). In comparison, in controls using only
purified PdR and Pdx without CYP154H1, NADH oxida-
tion rates of 1.6 nmol min−1 nmol−1 PdR were obtained
under the same assay conditions. Thus, PdR already
oxidizes NADH without the presence of a P450 monoox-
ygenase, but the rate is significantly lower compared to
reactions with CYP154H1.
Thermostability
In order to determine the thermal stability of the enzyme,
residual activity of purified CYP154H1 towards 1 was
measured at 25°C after incubation for 10 min at elevated
temperatures (Figure S3, Online Resource). It was found that
the enzyme hardly lost activity when incubated at 40°C, 50°C,
and 60°C. For higher temperatures, the decrease in activity
was more dramatic, which is in agreement with the optimum
growth temperature of T. fusca of 50–55°C (Lykidis et al.
2007). Nevertheless, even after incubation at 80°C, still 10%
of initial activity could be measured. Furthermore, the
apparent melting temperature of CYP154H1 was determined
by CD spectrometry to be 67°C.
Discussion
The moderately thermophilic soil bacterium T. fusca is a
rich source of valuable biocatalysts with high stability that
are still active at ambient temperature (Wilson 2004). The
genome sequence of this bacterium contains also ten open
reading frames coding for putative cytochrome P450
monooxygenases. Although it can be anticipated that the
P450s from T. fusca exhibit increased stability compared to
P450s from mesophilic hosts—a characteristic that is highly
desired for biocatalytic applications—none of them had
been studied in detail so far. In fact, the usually low
stability of P450 monooxygenases is one major limitation
for their use on industrial scale. Thus, there is a clear need
for the discovery of thermostable P450s with desired
activities and substrate specificities. Nevertheless, up to
now, only few naturally occurring, thermostable P450
monooxygenases have been reported in the literature and
the substrate specificities of only two of them are known
(Blasco et al. 2004; Koo et al. 2000, 2002; McLean et al.
1998).
In the present paper, we described the recombinant
expression and characterization of CYP154H1, the first
P450 monooxygenase from T. fusca that has been cloned
and studied regarding substrate specificity and stability. The
enzyme can be highly overexpressed in E. coli in active
form and purified with the help of an N-terminal his6-tag
(Table S1). Since the natural electron transfer partners of
this three-component P450 monooxygenase are unknown,
putidaredoxin reductase and putidaredoxin from P. putida
were employed to supply CYP154H1 with electrons. Using
this surrogate three-component system, the substrate spec-
ificity of CYP154H1 was investigated revealing a prefer-
ence for small (aromatic) compounds. Thus, it was shown
that the enzyme is able to enantioselectively convert
different arylaliphatic substrates (1, 4, and 8) to the
corresponding chiral products (2, 5, and 9, respectively,
Table 2), which represent key chiral building blocks in
organic synthesis. Of the different aliphatic compounds that
were tested, only 1-octene was transformed. Furthermore,
despite the 46% sequence identity with CYP154 from N.
farcinica IFM 10152—an enzyme that hydroxylates testos-
terone regio- and stereoselectively—CYP154H1 is not able
to convert steroids or even larger aromatic compounds like
naphthalene derivatives. This might be due to a smaller
active site compared to that of CYP154 from N. farcinica or
a restricted access for these compounds to the active site.
According to the homology models of CYP154H1 and
CYP154 from N. farcinica—both are based on the crystal
structure of CYP154C1 which shares 52% sequence
identity at the protein level with both P450s (Podust et al.
2003)—the active site shapes are rather similar. Further-
more, the expected substrate entrance channel of CYP154
from N. farcinica is even narrower than the one from
CYP154H1 (data not shown). Thus, reliable conclusions
about why larger compounds are not converted by this
P450 cannot be drawn based on the homology models. For
that, it will be necessary to solve the crystal structure of
CYP154H1 with a bound substrate in the active site, since
it is known for P450s that they undergo structural changes
upon substrate binding in order to adopt a structure that
better fits the substrate molecule into the active site (Li and
Poulos 1997; Raag et al. 1993).
Besides compounds 1, 4, and 8, different organic
sulfides (20a–d) are oxidized by CYP154H1 to the
corresponding sulfoxides (21a–d) in an enantioselective
fashion (Table 3). Such sulfoxides are also important due to
their use as chiral auxillaries in organic synthesis and their
Table 3 Conversion of 20a–c by CFE of E. coli C43(DE3)
(pACYCcamAB)(pIT2cyp154H1) containing active CYP154H1
from T. fusca as well as PdR and Pdx from P. putida (5 mM
substrate, 30°C)
Substrate Conversion (%) Product ratio (21:22) ee of 21 (%)
20a 55 77:23 56 (R)
20b 70 52:18 11 (R)
20c 41 95:5 20 (S)
20d 50 78:22 46 (S)
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use as building blocks in the pharmaceutical industry.
Another important feature of CYP154H1 is the selective
synthesis of 3-oxo-N-acetylindole (17) from N-acetylindole
(16) since the product is used as an important intermediate
in the synthesis of different phosphodiesterase inhibitors
(Weinbrenner et al. 2008), calcium channel blockers
(Shcherbakova and Nikoyukin 2008), and HIV inhibitors
(Kesteleyn et al. 2005).
Since CYP154H1 comes from a thermophilic host, the
enzyme was expected to display also a higher stability
compared to its mesophilic counterparts. Indeed, an
apparent melting temperature (Tm) of 67°C was determined
by circular dichroism. This apparent Tm is significantly
higher than the one found for CYP101A1 (P450cam, Tm=
54°C, measured by differential scanning calorimetry
(DSC)) but also much lower than the apparent Tm reported
for CYP119 (Tm=91°C, measured by DSC), a hyper-
thermostable cytochrome P450 monooxygenase from S.
solfataricus (McLean et al. 1998). This was also in
agreement with activity measurements showing that the
enzyme still displayed 54% of initial activity after heating
for 10 min at 65°C (Figure S3, Online Resource). Thus, the
enzyme exhibits improved stability compared to cyto-
chrome P450s from mesophilic hosts. Due to the low
stability of the applied electron transfer components, PdR
and Pdx, at elevated temperatures (Sevrioukova et al.
2003), it was not possible to determine the temperature
optimum of CYP154H1. Furthermore, the overall activity
of the surrogate three-component system seems to be rather
low. There is a big discrepancy between the rates of product
formation and NADH oxidation rates that were measured
for 1 and 8. This could be due to an insufficient transfer of
electrons from Pdx to the P450 as CYP154H1 and
CYP101A1 (the natural monooxygenase partner of PdR
and Pdx) share only 26% sequence identity on protein
level. For example, slow transfer of the second electron
(after binding of oxygen to the heme iron) during catalysis
can lead to uncoupling and formation of superoxide
(Karuzina and Archakov 1994). Thus, identification of the
natural electron transfer partners of CYP154H1 is of major
importance in order to optimize the performance of the
enzyme system. On the other hand, the used substrates
themselves might cause uncoupling in the P450 catalytic
cycle due to non-productive binding in the active site. As
an example, coupling efficiencies in the conversion of
styrene and thioanisole by the P450cam three-component
system were ≤10% in contrast to the tight coupling of
NADH consumption and substrate oxidation in the case of
camphor, the natural substrate of P450cam (Fruetel et al.
1992, 1994). Thus, we cannot exclude that much better
substrates with higher coupling efficiencies exist for
CYP154H1 since the natural substrate of this enzyme is
not known.
In summary, CYP154H1 from T. fusca constitutes a new
moderately thermostable P450 monooxygenase that can be
easily expressed in E. coli in high yield. The enzyme
represents a promising new biocatalyst for oxidative
reactions since it is able to produce a range of industrially
relevant compounds. To further improve the stereoselectiv-
ity of the enzyme, protein engineering and directed
evolution methods can be employed (Bell et al. 2001;
Jaeger and Reetz 2000; Seifert et al. 2009). Currently we
are working on the crystallization of CYP154H1 to
elucidate its three-dimensional structure. Furthermore, we
are trying to identify the natural electron transfer partners
from T. fusca to improve catalytic efficiency of the three-
component system in bioconversions.
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